

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 5.55644241 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.08948469 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.05808211 |
| 4 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.89024292 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.80542230 |
| 6 | vocalization behavior (GO:0071625) | 4.79412783 |
| 7 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.54705493 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.54125507 |
| 9 | glutamate receptor signaling pathway (GO:0007215) | 4.37007717 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.30139829 |
| 11 | exploration behavior (GO:0035640) | 4.18059415 |
| 12 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.11446531 |
| 13 | glutamate secretion (GO:0014047) | 4.06025488 |
| 14 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.05918196 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 4.05696342 |
| 16 | synaptic transmission, glutamatergic (GO:0035249) | 4.02379605 |
| 17 | protein localization to synapse (GO:0035418) | 4.01787869 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.93384474 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.92675343 |
| 20 | cellular response to ethanol (GO:0071361) | 3.91561409 |
| 21 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.87747252 |
| 22 | regulation of synapse structural plasticity (GO:0051823) | 3.80832339 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.80418539 |
| 24 | neuron-neuron synaptic transmission (GO:0007270) | 3.79206834 |
| 25 | neuronal action potential propagation (GO:0019227) | 3.74770893 |
| 26 | long-term memory (GO:0007616) | 3.73136046 |
| 27 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.71186804 |
| 28 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.70412718 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.70055964 |
| 30 | neuron cell-cell adhesion (GO:0007158) | 3.68814328 |
| 31 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.60970241 |
| 32 | dendritic spine morphogenesis (GO:0060997) | 3.58637918 |
| 33 | gamma-aminobutyric acid transport (GO:0015812) | 3.57414653 |
| 34 | neurotransmitter secretion (GO:0007269) | 3.54473427 |
| 35 | cellular potassium ion homeostasis (GO:0030007) | 3.53390979 |
| 36 | regulation of synaptic vesicle transport (GO:1902803) | 3.49324410 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.47817545 |
| 38 | adenosine receptor signaling pathway (GO:0001973) | 3.46433633 |
| 39 | regulation of postsynaptic membrane potential (GO:0060078) | 3.46041992 |
| 40 | regulation of synaptic plasticity (GO:0048167) | 3.44262035 |
| 41 | neuron recognition (GO:0008038) | 3.43154701 |
| 42 | long-term synaptic potentiation (GO:0060291) | 3.41499853 |
| 43 | L-amino acid import (GO:0043092) | 3.39409799 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 3.36091844 |
| 45 | layer formation in cerebral cortex (GO:0021819) | 3.29547368 |
| 46 | neuromuscular process controlling balance (GO:0050885) | 3.29223385 |
| 47 | regulation of mononuclear cell migration (GO:0071675) | 3.28569262 |
| 48 | synaptic vesicle endocytosis (GO:0048488) | 3.26642744 |
| 49 | axonal fasciculation (GO:0007413) | 3.26379528 |
| 50 | transmission of nerve impulse (GO:0019226) | 3.23693362 |
| 51 | positive regulation of synapse maturation (GO:0090129) | 3.23301927 |
| 52 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.23089122 |
| 53 | positive regulation of membrane potential (GO:0045838) | 3.23046530 |
| 54 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.21993943 |
| 55 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.20160907 |
| 56 | proline transport (GO:0015824) | 3.20095989 |
| 57 | dendrite morphogenesis (GO:0048813) | 3.17771844 |
| 58 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.17559150 |
| 59 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.15839477 |
| 60 | sodium ion export (GO:0071436) | 3.13238112 |
| 61 | regulation of macrophage chemotaxis (GO:0010758) | 3.07571554 |
| 62 | regulation of dendritic spine development (GO:0060998) | 3.07473120 |
| 63 | behavioral fear response (GO:0001662) | 3.03868124 |
| 64 | behavioral defense response (GO:0002209) | 3.03868124 |
| 65 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.02525623 |
| 66 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.02296716 |
| 67 | response to peptidoglycan (GO:0032494) | 3.02095796 |
| 68 | T-helper 1 type immune response (GO:0042088) | 3.00196532 |
| 69 | dendritic spine organization (GO:0097061) | 2.98598008 |
| 70 | membrane depolarization (GO:0051899) | 2.98275476 |
| 71 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.98063195 |
| 72 | regulation of female receptivity (GO:0045924) | 2.97195899 |
| 73 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.97041749 |
| 74 | macrophage activation (GO:0042116) | 2.94797488 |
| 75 | nerve growth factor signaling pathway (GO:0038180) | 2.94792183 |
| 76 | long term synaptic depression (GO:0060292) | 2.94328273 |
| 77 | innervation (GO:0060384) | 2.92794118 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.92031570 |
| 79 | cell communication by electrical coupling (GO:0010644) | 2.89212674 |
| 80 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.88665023 |
| 81 | response to auditory stimulus (GO:0010996) | 2.88490139 |
| 82 | membrane depolarization during action potential (GO:0086010) | 2.88407483 |
| 83 | positive regulation of heat generation (GO:0031652) | 2.88396884 |
| 84 | learning (GO:0007612) | 2.88381085 |
| 85 | positive regulation of dendritic spine development (GO:0060999) | 2.88199176 |
| 86 | activation of protein kinase A activity (GO:0034199) | 2.88050203 |
| 87 | protein localization to endosome (GO:0036010) | 2.86968438 |
| 88 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.86590277 |
| 89 | neurotransmitter transport (GO:0006836) | 2.85841036 |
| 90 | vesicle transport along microtubule (GO:0047496) | 2.84925361 |
| 91 | response to histamine (GO:0034776) | 2.84607489 |
| 92 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.83107281 |
| 93 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.82343851 |
| 94 | fear response (GO:0042596) | 2.81876431 |
| 95 | auditory behavior (GO:0031223) | 2.81666199 |
| 96 | behavioral response to cocaine (GO:0048148) | 2.81528835 |
| 97 | prepulse inhibition (GO:0060134) | 2.81291383 |
| 98 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.79262881 |
| 99 | regulation of fever generation (GO:0031620) | 2.77996848 |
| 100 | chemosensory behavior (GO:0007635) | 2.77930246 |
| 101 | regulation of neurotransmitter levels (GO:0001505) | 2.77665998 |
| 102 | neuronal ion channel clustering (GO:0045161) | 2.76846027 |
| 103 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.75411240 |
| 104 | regulation of neurotransmitter secretion (GO:0046928) | 2.75229519 |
| 105 | regulation of glutamate secretion (GO:0014048) | 2.74972109 |
| 106 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.72629861 |
| 107 | positive regulation of synaptic transmission (GO:0050806) | 2.72336849 |
| 108 | neuromuscular process controlling posture (GO:0050884) | 2.70245554 |
| 109 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.69998872 |
| 110 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.69956758 |
| 111 | regulation of synaptic transmission (GO:0050804) | 2.69436869 |
| 112 | regulation of ARF protein signal transduction (GO:0032012) | 2.69248945 |
| 113 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.68776066 |
| 114 | establishment of nucleus localization (GO:0040023) | 2.68471881 |
| 115 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.68092045 |
| 116 | neuromuscular process (GO:0050905) | 2.67555770 |
| 117 | amino acid import (GO:0043090) | 2.67282070 |
| 118 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.65278568 |
| 119 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.64947376 |
| 120 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.64947376 |
| 121 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.64947376 |
| 122 | modulation by symbiont of host immune response (GO:0052553) | 2.64947376 |
| 123 | positive regulation by symbiont of host defense response (GO:0052509) | 2.64947376 |
| 124 | modulation by symbiont of host defense response (GO:0052031) | 2.64947376 |
| 125 | cellular sodium ion homeostasis (GO:0006883) | 2.64826206 |
| 126 | cerebellar granule cell differentiation (GO:0021707) | 2.63814383 |
| 127 | microglial cell activation (GO:0001774) | 2.63518518 |
| 128 | germinal center formation (GO:0002467) | 2.62682306 |
| 129 | female mating behavior (GO:0060180) | 2.61961609 |
| 130 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.61835992 |
| 131 | negative regulation of amino acid transport (GO:0051956) | 2.61198675 |
| 132 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.54238195 |
| 133 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.52064843 |
| 134 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.51596047 |
| 135 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.46499053 |
| 136 | substrate-dependent cell migration (GO:0006929) | 2.44925036 |
| 137 | response to manganese ion (GO:0010042) | 2.44494029 |
| 138 | glycosphingolipid catabolic process (GO:0046479) | 2.41982806 |
| 139 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.39978545 |
| 140 | apoptotic cell clearance (GO:0043277) | 2.39803599 |
| 141 | monocyte chemotaxis (GO:0002548) | 2.39161487 |
| 142 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.36078386 |
| 143 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.33392528 |
| 144 | response to nerve growth factor (GO:1990089) | 2.33392528 |
| 145 | cortical actin cytoskeleton organization (GO:0030866) | 2.32498090 |
| 146 | regulation of heat generation (GO:0031650) | 2.30479510 |
| 147 | regulation of cholesterol storage (GO:0010885) | 2.29343455 |
| 148 | positive regulation of acute inflammatory response (GO:0002675) | 2.27762796 |
| 149 | positive regulation of macrophage cytokine production (GO:0060907) | 2.26021406 |
| 150 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.25719121 |
| 151 | endothelium development (GO:0003158) | 2.25665956 |
| 152 | positive regulation of phagocytosis (GO:0050766) | 2.25256072 |
| 153 | negative regulation of interleukin-17 production (GO:0032700) | 2.24654020 |
| 154 | neuron remodeling (GO:0016322) | 2.24100785 |
| 155 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.23242359 |
| 156 | cell adhesion mediated by integrin (GO:0033627) | 2.21758893 |
| 157 | oligosaccharide catabolic process (GO:0009313) | 2.21172194 |
| 158 | positive regulation of type 2 immune response (GO:0002830) | 2.21008970 |
| 159 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.19550336 |
| 160 | regulation of axon regeneration (GO:0048679) | 2.18264263 |
| 161 | regulation of neuron projection regeneration (GO:0070570) | 2.18264263 |
| 162 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.18218680 |
| 163 | Rap protein signal transduction (GO:0032486) | 2.17708011 |
| 164 | cortical cytoskeleton organization (GO:0030865) | 2.17481638 |
| 165 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.16326970 |
| 166 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.15499939 |
| 167 | response to muramyl dipeptide (GO:0032495) | 2.15478270 |
| 168 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.13641131 |
| 169 | negative regulation of vascular permeability (GO:0043116) | 2.13304119 |
| 170 | negative regulation of inclusion body assembly (GO:0090084) | 2.12519329 |
| 171 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.12174810 |
| 172 | positive regulation of chemokine secretion (GO:0090197) | 2.10825838 |
| 173 | positive regulation of leukocyte degranulation (GO:0043302) | 2.10700157 |
| 174 | glycolipid catabolic process (GO:0019377) | 2.09384975 |
| 175 | Notch signaling involved in heart development (GO:0061314) | 2.08954772 |
| 176 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.08797876 |
| 177 | Rac protein signal transduction (GO:0016601) | 2.08348786 |
| 178 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.07652854 |
| 179 | regulation of apoptotic cell clearance (GO:2000425) | 2.07257052 |
| 180 | regulation of interferon-alpha production (GO:0032647) | 2.05696063 |
| 181 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.05037366 |
| 182 | cAMP biosynthetic process (GO:0006171) | 2.04177562 |
| 183 | macroautophagy (GO:0016236) | 2.03605146 |
| 184 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.03444640 |
| 185 | positive regulation of cholesterol efflux (GO:0010875) | 2.01297621 |
| 186 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.00632515 |
| 187 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.00097073 |
| 188 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 1.99909560 |
| 189 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 1.98524949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.05712979 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.53484975 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.26094422 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.83933471 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.83181836 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71210021 |
| 7 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.49838130 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.48513200 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.48513200 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.48112879 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45698166 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35276084 |
| 13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.34498881 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33338926 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.30749225 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.26482974 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.24938659 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24317035 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16721245 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06617766 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.03712073 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92656114 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.90563584 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.89338643 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.88598514 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.86444145 |
| 27 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84060610 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.81915682 |
| 29 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81228162 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80915772 |
| 31 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.76967141 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.74467213 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74221298 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70871334 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70777508 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62214925 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.59874858 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59237863 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54781911 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53962152 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51910394 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50310596 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50083633 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49175453 |
| 45 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.44796042 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44554357 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.43913965 |
| 48 | TP53_16413492_ChIP-PET_HCT116_Human | 1.43727421 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41379032 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40843493 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40732646 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.40463660 |
| 53 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.40388730 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38585402 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36697357 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36545932 |
| 57 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35987058 |
| 58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35647799 |
| 59 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.35219468 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34726395 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34426567 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32482329 |
| 63 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30204630 |
| 64 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.29628430 |
| 65 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28605325 |
| 66 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.28344600 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28303310 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28270925 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27803420 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.26743421 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25855268 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25594059 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24637740 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24526853 |
| 75 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.23769902 |
| 76 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23219536 |
| 77 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22858289 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22369408 |
| 79 | AR_19668381_ChIP-Seq_PC3_Human | 1.20573030 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19445053 |
| 81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18974943 |
| 82 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18424121 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18182661 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17115874 |
| 85 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16567448 |
| 86 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15808216 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15749879 |
| 88 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.14591490 |
| 89 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14338559 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14024325 |
| 91 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13706605 |
| 92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13051217 |
| 93 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12979067 |
| 94 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12807876 |
| 95 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12072674 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10729737 |
| 97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10154235 |
| 98 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09569510 |
| 99 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08764924 |
| 100 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08128465 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06713541 |
| 102 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.05077353 |
| 103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03834931 |
| 104 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03756965 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03654549 |
| 106 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03253481 |
| 107 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03066675 |
| 108 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01412571 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01267052 |
| 110 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00689512 |
| 111 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99737785 |
| 112 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99626481 |
| 113 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99147374 |
| 114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98749266 |
| 115 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98145647 |
| 116 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.97671616 |
| 117 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97066604 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95870755 |
| 119 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95719336 |
| 120 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95510937 |
| 121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95510117 |
| 122 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95398763 |
| 123 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94591422 |
| 124 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.94580456 |
| 125 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94024644 |
| 126 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93883674 |
| 127 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93395288 |
| 128 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92797646 |
| 129 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92273634 |
| 130 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91661035 |
| 131 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91591781 |
| 132 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91531084 |
| 133 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.90356106 |
| 134 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90339111 |
| 135 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90329420 |
| 136 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90177381 |
| 137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89714604 |
| 138 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89714604 |
| 139 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89573004 |
| 140 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89359689 |
| 141 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89359689 |
| 142 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88869602 |
| 143 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.88313225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.17617774 |
| 2 | MP0003303_peritoneal_inflammation | 5.13896512 |
| 3 | MP0003880_abnormal_central_pattern | 4.77478350 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.17452224 |
| 5 | MP0009745_abnormal_behavioral_response | 3.49936965 |
| 6 | MP0004270_analgesia | 3.48975373 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.45811644 |
| 8 | MP0002064_seizures | 3.18312741 |
| 9 | MP0003724_increased_susceptibility_to | 3.15990154 |
| 10 | MP0002822_catalepsy | 3.02276253 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.84756938 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.81436228 |
| 13 | MP0009046_muscle_twitch | 2.80568377 |
| 14 | MP0006082_CNS_inflammation | 2.56279553 |
| 15 | MP0001486_abnormal_startle_reflex | 2.52503602 |
| 16 | MP0002272_abnormal_nervous_system | 2.44196333 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.42786527 |
| 18 | MP0002736_abnormal_nociception_after | 2.38075798 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.37747763 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.28879482 |
| 21 | MP0010368_abnormal_lymphatic_system | 2.23784553 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.21523806 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.21341266 |
| 24 | MP0002332_abnormal_exercise_endurance | 2.18060965 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.14472512 |
| 26 | MP0002735_abnormal_chemical_nociception | 2.11747502 |
| 27 | MP0009840_abnormal_foam_cell | 2.10440308 |
| 28 | MP0000343_altered_response_to | 2.09067974 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 2.05083621 |
| 30 | MP0003195_calcinosis | 1.94480245 |
| 31 | MP0006054_spinal_hemorrhage | 1.93764128 |
| 32 | MP0003329_amyloid_beta_deposits | 1.92979625 |
| 33 | MP0003828_pulmonary_edema | 1.92653678 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.85976733 |
| 35 | MP0008004_abnormal_stomach_pH | 1.83651350 |
| 36 | MP0004858_abnormal_nervous_system | 1.83561513 |
| 37 | MP0000778_abnormal_nervous_system | 1.79802990 |
| 38 | MP0003091_abnormal_cell_migration | 1.74521373 |
| 39 | MP0002419_abnormal_innate_immunity | 1.73281834 |
| 40 | MP0003436_decreased_susceptibility_to | 1.69579485 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.69073912 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.67448623 |
| 43 | MP0000569_abnormal_digit_pigmentation | 1.65415077 |
| 44 | MP0008569_lethality_at_weaning | 1.64354298 |
| 45 | MP0009764_decreased_sensitivity_to | 1.64069958 |
| 46 | MP0001970_abnormal_pain_threshold | 1.63283863 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.61013381 |
| 48 | MP0003690_abnormal_glial_cell | 1.60454523 |
| 49 | MP0004811_abnormal_neuron_physiology | 1.59645583 |
| 50 | MP0009785_altered_susceptibility_to | 1.58683270 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.58431412 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.57982910 |
| 53 | MP0002184_abnormal_innervation | 1.55428501 |
| 54 | MP0004924_abnormal_behavior | 1.54954154 |
| 55 | MP0005386_behavior/neurological_phenoty | 1.54954154 |
| 56 | MP0003633_abnormal_nervous_system | 1.54035176 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.48780985 |
| 58 | MP0009278_abnormal_bone_marrow | 1.45730611 |
| 59 | MP0004885_abnormal_endolymph | 1.43998550 |
| 60 | MP0000955_abnormal_spinal_cord | 1.35876020 |
| 61 | MP0001879_abnormal_lymphatic_vessel | 1.35589963 |
| 62 | MP0003075_altered_response_to | 1.34353907 |
| 63 | MP0003879_abnormal_hair_cell | 1.33123499 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.32458936 |
| 65 | MP0002066_abnormal_motor_capabilities/c | 1.31518330 |
| 66 | MP0003631_nervous_system_phenotype | 1.29743603 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.29279332 |
| 68 | MP0005451_abnormal_body_composition | 1.29107681 |
| 69 | MP0005164_abnormal_response_to | 1.27425708 |
| 70 | MP0000604_amyloidosis | 1.24798205 |
| 71 | MP0002882_abnormal_neuron_morphology | 1.23956160 |
| 72 | MP0001790_abnormal_immune_system | 1.20973564 |
| 73 | MP0005387_immune_system_phenotype | 1.20973564 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.20914946 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 1.19577776 |
| 76 | MP0001545_abnormal_hematopoietic_system | 1.19577776 |
| 77 | MP0003787_abnormal_imprinting | 1.18208096 |
| 78 | MP0004883_abnormal_blood_vessel | 1.18142345 |
| 79 | MP0008874_decreased_physiological_sensi | 1.17890988 |
| 80 | MP0005025_abnormal_response_to | 1.15152974 |
| 81 | MP0003448_altered_tumor_morphology | 1.14088764 |
| 82 | MP0006276_abnormal_autonomic_nervous | 1.13451448 |
| 83 | MP0001502_abnormal_circadian_rhythm | 1.12578387 |
| 84 | MP0001915_intracranial_hemorrhage | 1.11000961 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 1.10550702 |
| 86 | MP0005000_abnormal_immune_tolerance | 1.07015651 |
| 87 | MP0005165_increased_susceptibility_to | 1.07003224 |
| 88 | MP0004145_abnormal_muscle_electrophysio | 1.06926563 |
| 89 | MP0001529_abnormal_vocalization | 1.06470454 |
| 90 | MP0003705_abnormal_hypodermis_morpholog | 1.05576620 |
| 91 | MP0005409_darkened_coat_color | 1.04455224 |
| 92 | MP0003950_abnormal_plasma_membrane | 1.04181891 |
| 93 | MP0001177_atelectasis | 1.03022737 |
| 94 | MP0004510_myositis | 1.02832349 |
| 95 | MP0000920_abnormal_myelination | 1.02390365 |
| 96 | MP0002152_abnormal_brain_morphology | 1.01887675 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 1.01366469 |
| 98 | MP0001905_abnormal_dopamine_level | 1.00902074 |
| 99 | MP0000249_abnormal_blood_vessel | 1.00616635 |
| 100 | MP0003632_abnormal_nervous_system | 0.99154173 |
| 101 | MP0004142_abnormal_muscle_tone | 0.98566296 |
| 102 | MP0008961_abnormal_basal_metabolism | 0.98521263 |
| 103 | MP0005310_abnormal_salivary_gland | 0.98135044 |
| 104 | MP0005535_abnormal_body_temperature | 0.97852036 |
| 105 | MP0000767_abnormal_smooth_muscle | 0.96891358 |
| 106 | MP0001984_abnormal_olfaction | 0.94575956 |
| 107 | MP0004085_abnormal_heartbeat | 0.94543793 |
| 108 | MP0004484_altered_response_of | 0.94470363 |
| 109 | MP0001188_hyperpigmentation | 0.93044273 |
| 110 | MP0002069_abnormal_eating/drinking_beha | 0.92223976 |
| 111 | MP0004272_abnormal_basement_membrane | 0.91667204 |
| 112 | MP0005464_abnormal_platelet_physiology | 0.91112408 |
| 113 | MP0003279_aneurysm | 0.90164826 |
| 114 | MP0004947_skin_inflammation | 0.89228635 |
| 115 | MP0010352_gastrointestinal_tract_polyps | 0.88796869 |
| 116 | MP0003634_abnormal_glial_cell | 0.88238141 |
| 117 | MP0005671_abnormal_response_to | 0.87020686 |
| 118 | MP0002090_abnormal_vision | 0.86924331 |
| 119 | MP0002229_neurodegeneration | 0.86735126 |
| 120 | MP0005645_abnormal_hypothalamus_physiol | 0.85793705 |
| 121 | MP0002452_abnormal_antigen_presenting | 0.85100641 |
| 122 | MP0002168_other_aberrant_phenotype | 0.85048390 |
| 123 | MP0002877_abnormal_melanocyte_morpholog | 0.84560503 |
| 124 | MP0005085_abnormal_gallbladder_physiolo | 0.84492138 |
| 125 | MP0004130_abnormal_muscle_cell | 0.81436903 |
| 126 | MP0002723_abnormal_immune_serum | 0.81253242 |
| 127 | MP0003566_abnormal_cell_adhesion | 0.81147067 |
| 128 | MP0008872_abnormal_physiological_respon | 0.80679082 |
| 129 | MP0002837_dystrophic_cardiac_calcinosis | 0.79794938 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.78631684 |
| 131 | MP0005388_respiratory_system_phenotype | 0.77503471 |
| 132 | MP0002133_abnormal_respiratory_system | 0.77503471 |
| 133 | MP0004215_abnormal_myocardial_fiber | 0.77305562 |
| 134 | MP0000751_myopathy | 0.77063654 |
| 135 | MP0003045_fibrosis | 0.77040395 |
| 136 | MP0001835_abnormal_antigen_presentation | 0.76043645 |
| 137 | MP0004742_abnormal_vestibular_system | 0.75396914 |
| 138 | MP0008469_abnormal_protein_level | 0.73988708 |
| 139 | MP0005023_abnormal_wound_healing | 0.72029339 |
| 140 | MP0003656_abnormal_erythrocyte_physiolo | 0.71790859 |
| 141 | MP0001845_abnormal_inflammatory_respons | 0.70587662 |
| 142 | MP0003137_abnormal_impulse_conducting | 0.69790724 |
| 143 | MP0001963_abnormal_hearing_physiology | 0.65725166 |
| 144 | MP0005623_abnormal_meninges_morphology | 0.64571048 |
| 145 | MP0005360_urolithiasis | 0.64402054 |
| 146 | MP0005166_decreased_susceptibility_to | 0.61299447 |
| 147 | MP0010329_abnormal_lipoprotein_level | 0.60082284 |
| 148 | MP0005595_abnormal_vascular_smooth | 0.59818171 |
| 149 | MP0005551_abnormal_eye_electrophysiolog | 0.56957668 |
| 150 | MP0010386_abnormal_urinary_bladder | 0.55918856 |
| 151 | MP0000013_abnormal_adipose_tissue | 0.55813019 |
| 152 | MP0004233_abnormal_muscle_weight | 0.54698344 |
| 153 | MP0005187_abnormal_penis_morphology | 0.51729604 |
| 154 | MP0003283_abnormal_digestive_organ | 0.51233416 |
| 155 | MP0002139_abnormal_hepatobiliary_system | 0.50133729 |
| 156 | MP0005365_abnormal_bile_salt | 0.50037940 |
| 157 | MP0002752_abnormal_somatic_nervous | 0.48964849 |
| 158 | MP0003191_abnormal_cellular_cholesterol | 0.47993026 |
| 159 | MP0001664_abnormal_digestion | 0.46086653 |
| 160 | MP0010769_abnormal_survival | 0.45929711 |
| 161 | MP0003252_abnormal_bile_duct | 0.45905992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.53544903 |
| 2 | Myokymia (HP:0002411) | 6.30869043 |
| 3 | Focal seizures (HP:0007359) | 5.67631779 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.95919111 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.95919111 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.95919111 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.82375188 |
| 8 | Glomerulonephritis (HP:0000099) | 4.74434601 |
| 9 | Visual hallucinations (HP:0002367) | 4.43260260 |
| 10 | Action tremor (HP:0002345) | 4.36358483 |
| 11 | Atonic seizures (HP:0010819) | 4.31648536 |
| 12 | Epileptic encephalopathy (HP:0200134) | 4.25854354 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 4.20492550 |
| 14 | Febrile seizures (HP:0002373) | 4.08232817 |
| 15 | Disinhibition (HP:0000734) | 3.95020701 |
| 16 | Absence seizures (HP:0002121) | 3.93025250 |
| 17 | Hyperventilation (HP:0002883) | 3.79171539 |
| 18 | Dialeptic seizures (HP:0011146) | 3.73922669 |
| 19 | Generalized tonic-clonic seizures (HP:0002069) | 3.69602808 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 3.69455981 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 3.40060821 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.38876460 |
| 23 | Dysmetria (HP:0001310) | 3.36415217 |
| 24 | Broad-based gait (HP:0002136) | 3.35729605 |
| 25 | Gaze-evoked nystagmus (HP:0000640) | 3.31479702 |
| 26 | Poor eye contact (HP:0000817) | 3.31067926 |
| 27 | Cerebral inclusion bodies (HP:0100314) | 3.30858265 |
| 28 | Apathy (HP:0000741) | 3.26836478 |
| 29 | Postural instability (HP:0002172) | 3.25865630 |
| 30 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.20661457 |
| 31 | Abnormal social behavior (HP:0012433) | 3.20425900 |
| 32 | Impaired social interactions (HP:0000735) | 3.20425900 |
| 33 | Hematochezia (HP:0002573) | 3.14667940 |
| 34 | Neurofibrillary tangles (HP:0002185) | 3.14336045 |
| 35 | Depression (HP:0000716) | 2.97695928 |
| 36 | Diminished motivation (HP:0000745) | 2.97042325 |
| 37 | Cerebral aneurysm (HP:0004944) | 2.96534829 |
| 38 | Mutism (HP:0002300) | 2.95381442 |
| 39 | Myocardial infarction (HP:0001658) | 2.94913377 |
| 40 | Drooling (HP:0002307) | 2.94710687 |
| 41 | Excessive salivation (HP:0003781) | 2.94710687 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.92629217 |
| 43 | Truncal ataxia (HP:0002078) | 2.92610988 |
| 44 | Abnormality of the lower motor neuron (HP:0002366) | 2.90842460 |
| 45 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.90388213 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.89125940 |
| 47 | Intention tremor (HP:0002080) | 2.88593070 |
| 48 | Abnormality of complement system (HP:0005339) | 2.84558832 |
| 49 | Status epilepticus (HP:0002133) | 2.82769036 |
| 50 | Amblyopia (HP:0000646) | 2.80124887 |
| 51 | Diplopia (HP:0000651) | 2.79969829 |
| 52 | Abnormality of binocular vision (HP:0011514) | 2.79969829 |
| 53 | Hemiparesis (HP:0001269) | 2.78864502 |
| 54 | Genetic anticipation (HP:0003743) | 2.77833043 |
| 55 | Agnosia (HP:0010524) | 2.77684471 |
| 56 | Anxiety (HP:0000739) | 2.77157067 |
| 57 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.75986983 |
| 58 | Scanning speech (HP:0002168) | 2.75343293 |
| 59 | Loss of speech (HP:0002371) | 2.74436720 |
| 60 | Hemiplegia (HP:0002301) | 2.70113880 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.69416479 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.68609564 |
| 63 | Abnormality of macrophages (HP:0004311) | 2.65248838 |
| 64 | Nuclear cataract (HP:0100018) | 2.63130962 |
| 65 | Axonal loss (HP:0003447) | 2.60621486 |
| 66 | Esophageal varix (HP:0002040) | 2.60162581 |
| 67 | Retrobulbar optic neuritis (HP:0100654) | 2.58096043 |
| 68 | Optic neuritis (HP:0100653) | 2.58096043 |
| 69 | Impaired smooth pursuit (HP:0007772) | 2.56421154 |
| 70 | Upper motor neuron abnormality (HP:0002127) | 2.55157521 |
| 71 | Dysmetric saccades (HP:0000641) | 2.51181705 |
| 72 | Orchitis (HP:0100796) | 2.50475612 |
| 73 | Abnormal eating behavior (HP:0100738) | 2.48480793 |
| 74 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.47041422 |
| 75 | Recurrent bacterial skin infections (HP:0005406) | 2.44618137 |
| 76 | Torticollis (HP:0000473) | 2.43676774 |
| 77 | Nephritis (HP:0000123) | 2.43347903 |
| 78 | Spontaneous hematomas (HP:0007420) | 2.43229300 |
| 79 | Stereotypic behavior (HP:0000733) | 2.41240763 |
| 80 | Amyloidosis (HP:0011034) | 2.40894772 |
| 81 | Ankle clonus (HP:0011448) | 2.40618743 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40261015 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40261015 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40261015 |
| 85 | Absent speech (HP:0001344) | 2.37986781 |
| 86 | Epileptiform EEG discharges (HP:0011182) | 2.36229530 |
| 87 | Impaired vibratory sensation (HP:0002495) | 2.35849244 |
| 88 | Eczematoid dermatitis (HP:0000976) | 2.34552937 |
| 89 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33862853 |
| 90 | Mucopolysacchariduria (HP:0008155) | 2.33862853 |
| 91 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.32672175 |
| 92 | Bradykinesia (HP:0002067) | 2.32132470 |
| 93 | Urinary urgency (HP:0000012) | 2.31453983 |
| 94 | Neuronal loss in central nervous system (HP:0002529) | 2.30361317 |
| 95 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.28739988 |
| 96 | Spastic gait (HP:0002064) | 2.28352063 |
| 97 | Focal dystonia (HP:0004373) | 2.26503037 |
| 98 | Abnormality of the corticospinal tract (HP:0002492) | 2.22117203 |
| 99 | Lower limb asymmetry (HP:0100559) | 2.21918758 |
| 100 | Conjunctival telangiectasia (HP:0000524) | 2.21371670 |
| 101 | Annular pancreas (HP:0001734) | 2.19516753 |
| 102 | Termporal pattern (HP:0011008) | 2.18511563 |
| 103 | Insidious onset (HP:0003587) | 2.18511563 |
| 104 | EEG with generalized epileptiform discharges (HP:0011198) | 2.16433747 |
| 105 | Recurrent abscess formation (HP:0002722) | 2.15458345 |
| 106 | Generalized myoclonic seizures (HP:0002123) | 2.14851000 |
| 107 | Dementia (HP:0000726) | 2.12591909 |
| 108 | Blue irides (HP:0000635) | 2.12498188 |
| 109 | Peripheral demyelination (HP:0011096) | 2.11757717 |
| 110 | Cerebral hemorrhage (HP:0001342) | 2.10159931 |
| 111 | Memory impairment (HP:0002354) | 2.05779319 |
| 112 | Onion bulb formation (HP:0003383) | 2.04778678 |
| 113 | Autoimmune thrombocytopenia (HP:0001973) | 2.04404065 |
| 114 | Global brain atrophy (HP:0002283) | 2.04159988 |
| 115 | Hypsarrhythmia (HP:0002521) | 2.04078147 |
| 116 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03098949 |
| 117 | Abnormality of salivation (HP:0100755) | 2.01081683 |
| 118 | Difficulty running (HP:0009046) | 2.00447545 |
| 119 | Aqueductal stenosis (HP:0002410) | 1.99724908 |
| 120 | Lower limb muscle weakness (HP:0007340) | 1.99722286 |
| 121 | Mediastinal lymphadenopathy (HP:0100721) | 1.99090183 |
| 122 | Papilledema (HP:0001085) | 1.98325506 |
| 123 | Rapidly progressive (HP:0003678) | 1.97990441 |
| 124 | Megalencephaly (HP:0001355) | 1.97342342 |
| 125 | Progressive inability to walk (HP:0002505) | 1.96407182 |
| 126 | Incomplete penetrance (HP:0003829) | 1.95357186 |
| 127 | Craniofacial dystonia (HP:0012179) | 1.94124028 |
| 128 | Gait ataxia (HP:0002066) | 1.93631205 |
| 129 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90437988 |
| 130 | Tetraparesis (HP:0002273) | 1.89934855 |
| 131 | Pointed chin (HP:0000307) | 1.86947748 |
| 132 | Psychosis (HP:0000709) | 1.86668425 |
| 133 | Portal hypertension (HP:0001409) | 1.86574841 |
| 134 | Abnormality of the periventricular white matter (HP:0002518) | 1.84748188 |
| 135 | Decreased motor nerve conduction velocity (HP:0003431) | 1.84392252 |
| 136 | Lower limb amyotrophy (HP:0007210) | 1.83491029 |
| 137 | Abnormality of saccadic eye movements (HP:0000570) | 1.83329404 |
| 138 | Myositis (HP:0100614) | 1.82969966 |
| 139 | Exotropia (HP:0000577) | 1.82061235 |
| 140 | Adactyly (HP:0009776) | 1.79237216 |
| 141 | Arterial tortuosity (HP:0005116) | 1.79165174 |
| 142 | Rigidity (HP:0002063) | 1.77322040 |
| 143 | Ventricular fibrillation (HP:0001663) | 1.77150905 |
| 144 | Personality changes (HP:0000751) | 1.77066998 |
| 145 | Frequent falls (HP:0002359) | 1.76406767 |
| 146 | Clumsiness (HP:0002312) | 1.75794998 |
| 147 | Thickened helices (HP:0000391) | 1.74671535 |
| 148 | Inability to walk (HP:0002540) | 1.73158031 |
| 149 | Hammertoe (HP:0001765) | 1.72871393 |
| 150 | Generalized hypopigmentation of hair (HP:0011358) | 1.72110430 |
| 151 | Fair hair (HP:0002286) | 1.70335602 |
| 152 | Hemoptysis (HP:0002105) | 1.70324069 |
| 153 | Gingivitis (HP:0000230) | 1.70188623 |
| 154 | Pathologic fracture (HP:0002756) | 1.68835926 |
| 155 | Vertigo (HP:0002321) | 1.68749997 |
| 156 | Keratoconjunctivitis sicca (HP:0001097) | 1.67857435 |
| 157 | Increased CSF protein (HP:0002922) | 1.66702247 |
| 158 | Complement deficiency (HP:0004431) | 1.66642009 |
| 159 | Obstructive sleep apnea (HP:0002870) | 1.66273757 |
| 160 | Inappropriate behavior (HP:0000719) | 1.66098388 |
| 161 | Anosmia (HP:0000458) | 1.65887432 |
| 162 | Urinary incontinence (HP:0000020) | 1.65840693 |
| 163 | Retinal atrophy (HP:0001105) | 1.64849032 |
| 164 | Protruding tongue (HP:0010808) | 1.64614807 |
| 165 | Spastic tetraparesis (HP:0001285) | 1.64034768 |
| 166 | Spinal muscular atrophy (HP:0007269) | 1.63256907 |
| 167 | Abnormality of the hepatic vasculature (HP:0006707) | 1.61543624 |
| 168 | Aplasia of the phalanges of the hand (HP:0009802) | 1.61420184 |
| 169 | Aplasia involving bones of the extremities (HP:0009825) | 1.61420184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.63291745 |
| 2 | NTRK3 | 4.58271541 |
| 3 | TIE1 | 4.06594608 |
| 4 | TGFBR2 | 3.82553251 |
| 5 | IRAK3 | 3.49924883 |
| 6 | MAP3K9 | 3.35881957 |
| 7 | RIPK4 | 2.95256259 |
| 8 | MAP3K4 | 2.56395326 |
| 9 | DAPK2 | 2.41501848 |
| 10 | MINK1 | 2.34290748 |
| 11 | KSR2 | 2.17877750 |
| 12 | MARK1 | 2.02824432 |
| 13 | TNIK | 2.02125172 |
| 14 | PAK6 | 1.92791540 |
| 15 | BLK | 1.89203637 |
| 16 | MAP3K14 | 1.86734707 |
| 17 | MOS | 1.86587750 |
| 18 | MAP2K7 | 1.84687545 |
| 19 | MAP2K4 | 1.82500347 |
| 20 | KSR1 | 1.78889918 |
| 21 | NTRK2 | 1.78034373 |
| 22 | NTRK1 | 1.76414206 |
| 23 | FES | 1.73644892 |
| 24 | PRKD3 | 1.73319919 |
| 25 | CAMKK1 | 1.72948532 |
| 26 | MAP3K13 | 1.72877332 |
| 27 | SIK2 | 1.58040369 |
| 28 | CSK | 1.54177548 |
| 29 | PLK2 | 1.44748158 |
| 30 | EPHA3 | 1.41109125 |
| 31 | DAPK1 | 1.40674119 |
| 32 | PTK2B | 1.40640223 |
| 33 | CDK5 | 1.39737073 |
| 34 | MATK | 1.37100978 |
| 35 | TYRO3 | 1.35704867 |
| 36 | STK38 | 1.32889876 |
| 37 | TYK2 | 1.31697251 |
| 38 | JAK1 | 1.25930954 |
| 39 | PRKCG | 1.23446889 |
| 40 | GRK5 | 1.23325051 |
| 41 | CASK | 1.22734679 |
| 42 | PRPF4B | 1.22118871 |
| 43 | PNCK | 1.16146261 |
| 44 | ARAF | 1.11619047 |
| 45 | CAMK1G | 1.09770082 |
| 46 | ACVR1B | 1.08841319 |
| 47 | MAP3K12 | 1.07205348 |
| 48 | PDGFRB | 1.07081778 |
| 49 | MAP3K2 | 1.06320791 |
| 50 | CAMK2A | 1.05173862 |
| 51 | FGR | 1.02095378 |
| 52 | SGK223 | 0.99813539 |
| 53 | SGK494 | 0.99813539 |
| 54 | CAMK2B | 0.98716044 |
| 55 | SGK2 | 0.97434244 |
| 56 | TBK1 | 0.96401699 |
| 57 | RAF1 | 0.95306226 |
| 58 | CAMKK2 | 0.94970085 |
| 59 | BMPR2 | 0.92356376 |
| 60 | JAK2 | 0.90477119 |
| 61 | SGK3 | 0.89315271 |
| 62 | CAMK1 | 0.89178246 |
| 63 | MAPK13 | 0.89030801 |
| 64 | CSF1R | 0.87954697 |
| 65 | RET | 0.84393801 |
| 66 | IRAK2 | 0.83789682 |
| 67 | PDPK1 | 0.80937881 |
| 68 | SGK1 | 0.80299522 |
| 69 | DMPK | 0.80197108 |
| 70 | PRKCH | 0.79749496 |
| 71 | STK11 | 0.77497625 |
| 72 | MAP3K11 | 0.76158332 |
| 73 | PDK1 | 0.75649688 |
| 74 | RIPK1 | 0.74112048 |
| 75 | IRAK1 | 0.72089295 |
| 76 | FGFR2 | 0.72005150 |
| 77 | IRAK4 | 0.72001091 |
| 78 | MAP3K7 | 0.70545996 |
| 79 | JAK3 | 0.66431096 |
| 80 | MARK2 | 0.64704238 |
| 81 | CAMK4 | 0.63449712 |
| 82 | ADRBK2 | 0.61738095 |
| 83 | TTN | 0.60728544 |
| 84 | CDK18 | 0.60502912 |
| 85 | PAK3 | 0.60481010 |
| 86 | MAP3K3 | 0.60391740 |
| 87 | FGFR3 | 0.59861300 |
| 88 | PRKAA2 | 0.59155934 |
| 89 | PHKG2 | 0.58722652 |
| 90 | PHKG1 | 0.58722652 |
| 91 | PRKCE | 0.58460141 |
| 92 | CDK15 | 0.58163834 |
| 93 | MAPK7 | 0.57262472 |
| 94 | IKBKE | 0.57171800 |
| 95 | FYN | 0.56777659 |
| 96 | PRKCZ | 0.56386835 |
| 97 | CDK6 | 0.56230354 |
| 98 | ZAP70 | 0.55990583 |
| 99 | FER | 0.55199910 |
| 100 | CDK14 | 0.54451224 |
| 101 | RPS6KA2 | 0.53851424 |
| 102 | RPS6KA3 | 0.52129985 |
| 103 | PINK1 | 0.51983029 |
| 104 | MAP2K3 | 0.51777239 |
| 105 | OXSR1 | 0.51771592 |
| 106 | TAOK2 | 0.51626918 |
| 107 | UHMK1 | 0.51385388 |
| 108 | CAMK1D | 0.51010351 |
| 109 | CHUK | 0.50907973 |
| 110 | YES1 | 0.50099220 |
| 111 | MAPK12 | 0.48964158 |
| 112 | LATS2 | 0.48959331 |
| 113 | MAP3K5 | 0.47921994 |
| 114 | SIK3 | 0.47882988 |
| 115 | CAMK2D | 0.47744444 |
| 116 | TAOK1 | 0.47696738 |
| 117 | DYRK1A | 0.47574979 |
| 118 | EPHB2 | 0.47229130 |
| 119 | MAP2K1 | 0.47114720 |
| 120 | NEK6 | 0.46777682 |
| 121 | MAP3K1 | 0.46764959 |
| 122 | ROCK2 | 0.46642813 |
| 123 | NEK9 | 0.46337790 |
| 124 | CDK11A | 0.45578234 |
| 125 | EGFR | 0.45562998 |
| 126 | CAMK2G | 0.45093742 |
| 127 | GRK7 | 0.44953511 |
| 128 | MAPK10 | 0.44517583 |
| 129 | ICK | 0.41792888 |
| 130 | WNK1 | 0.41645046 |
| 131 | CSNK1G2 | 0.41172552 |
| 132 | INSRR | 0.40950268 |
| 133 | EPHB1 | 0.40611137 |
| 134 | ABL2 | 0.40412596 |
| 135 | PRKCQ | 0.39460634 |
| 136 | INSR | 0.39230887 |
| 137 | PDGFRA | 0.38967446 |
| 138 | PKN1 | 0.38333774 |
| 139 | FGFR4 | 0.37354321 |
| 140 | DDR2 | 0.36942748 |
| 141 | CDK19 | 0.36691417 |
| 142 | GSK3A | 0.36650782 |
| 143 | CDC42BPA | 0.36374311 |
| 144 | MAP3K6 | 0.34788468 |
| 145 | PTK2 | 0.34221332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.41893414 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.62633217 |
| 3 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.54233362 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.48600948 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.42663769 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.31064807 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.28218451 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.24143050 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23553140 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.22077426 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.18654695 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.13557856 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.09678583 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94361728 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93443856 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.88602447 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.86998807 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.85382160 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.80706574 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79487132 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74321362 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.71293476 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.70615706 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69214897 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.65123130 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.63612559 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58543817 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58298860 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.57141308 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56369837 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.55191549 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.54428704 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.52876715 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.50570846 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.49714099 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43440809 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.43059532 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40977025 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.39317072 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38749974 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.37245767 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35450709 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30494518 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28582107 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27220729 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.26749541 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.25170928 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24613652 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.21095133 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.20673501 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 1.18328615 |
| 52 | Glioma_Homo sapiens_hsa05214 | 1.17497130 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16660017 |
| 54 | Axon guidance_Homo sapiens_hsa04360 | 1.13928877 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13698079 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12438919 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11768340 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08306139 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06379266 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.05125340 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.03274242 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02956508 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02675402 |
| 64 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02219827 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 1.00585188 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99188360 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95249232 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92051699 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91218516 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91075789 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89643871 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.88449621 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 0.86331766 |
| 74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86162787 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86013037 |
| 76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83094655 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82038812 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81271861 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80720708 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78499079 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78029723 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76226196 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76177278 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75034509 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72183818 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71677693 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71602354 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71557516 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70782506 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69446711 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68962383 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68243654 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68226463 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.66158788 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.63930840 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63703028 |
| 97 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63374932 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62526638 |
| 99 | Focal adhesion_Homo sapiens_hsa04510 | 0.62465838 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61405249 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60620817 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59978841 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.58544055 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58402077 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57552933 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57180425 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.56523723 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55343461 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55088421 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53415198 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.53134519 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52814850 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.52189849 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52054844 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51886392 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50993784 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50448231 |
| 118 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48375647 |
| 119 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46100849 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46079991 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45693042 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44876295 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42363326 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41613904 |
| 125 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41552166 |
| 126 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40893318 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.40435779 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39906539 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39043641 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37903270 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35238721 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35037219 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34939276 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33369594 |
| 135 | Platelet activation_Homo sapiens_hsa04611 | 0.32017669 |
| 136 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30794135 |
| 137 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.30300716 |
| 138 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29620299 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28972609 |
| 140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27851003 |
| 141 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27035823 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26685528 |
| 143 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.25375822 |

